JPWO2021037212A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021037212A5 JPWO2021037212A5 JP2022513603A JP2022513603A JPWO2021037212A5 JP WO2021037212 A5 JPWO2021037212 A5 JP WO2021037212A5 JP 2022513603 A JP2022513603 A JP 2022513603A JP 2022513603 A JP2022513603 A JP 2022513603A JP WO2021037212 A5 JPWO2021037212 A5 JP WO2021037212A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- pharmaceutical composition
- composition according
- pharmaceutically acceptable
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019103677 | 2019-08-30 | ||
| CNPCT/CN2019/103677 | 2019-08-30 | ||
| PCT/CN2020/112143 WO2021037212A1 (zh) | 2019-08-30 | 2020-08-28 | 用于对抗代谢疾病的组合物及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022546987A JP2022546987A (ja) | 2022-11-10 |
| JPWO2021037212A5 true JPWO2021037212A5 (zh) | 2023-09-06 |
Family
ID=74683374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513603A Pending JP2022546987A (ja) | 2019-08-30 | 2020-08-28 | 代謝性疾患と闘うために使用される組成物およびその組成物の使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220323408A1 (zh) |
| EP (1) | EP4023225A4 (zh) |
| JP (1) | JP2022546987A (zh) |
| KR (1) | KR20220054351A (zh) |
| CN (1) | CN114364385A (zh) |
| AU (1) | AU2020339557A1 (zh) |
| CA (1) | CA3152868A1 (zh) |
| IL (1) | IL290927A (zh) |
| WO (1) | WO2021037212A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4069209A4 (en) * | 2019-12-05 | 2024-04-10 | Flagship Pioneering Innovations V Inc | ACYLATED ACTIVE AGENTS AND METHODS OF USE THEREOF FOR THE TREATMENT OF METABOLIC DISEASES AND NON-ALCOHOLIC FATTY LIVER DISEASE |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5127093B1 (zh) | 1970-11-11 | 1976-08-10 | ||
| AU570112B2 (en) | 1984-04-02 | 1988-03-03 | Cornell Research Foundation Inc. | Aminocarnitines |
| HUT65327A (en) | 1992-06-11 | 1994-05-02 | Sandoz Ag | Process for producing phosphinyloxy-propyl-ammonium inner sact derwatives ang pharmateutical preparations containing them |
| IT1299266B1 (it) | 1998-05-15 | 2000-02-29 | Sigma Tau Ind Farmaceuti | Inibitori reversibili della carnitina palmitoil trasferasi |
| WO2008111956A2 (en) * | 2007-03-09 | 2008-09-18 | Symcopeia Company | Fatty acid oxidation inhibitors treating hyperglycemia and related disorders |
| US20110275649A1 (en) * | 2010-05-05 | 2011-11-10 | Palmetto Pharmaceuticals Llc | Combination therapy for the prevention of statin induced diabetes |
| JP2014501759A (ja) * | 2010-12-21 | 2014-01-23 | ネステク ソシエテ アノニム | 動物の血糖管理に適した方法及び組成物 |
-
2020
- 2020-08-28 EP EP20856770.1A patent/EP4023225A4/en active Pending
- 2020-08-28 KR KR1020227009807A patent/KR20220054351A/ko unknown
- 2020-08-28 CN CN202080060415.1A patent/CN114364385A/zh active Pending
- 2020-08-28 US US17/639,181 patent/US20220323408A1/en active Pending
- 2020-08-28 AU AU2020339557A patent/AU2020339557A1/en active Pending
- 2020-08-28 WO PCT/CN2020/112143 patent/WO2021037212A1/zh active Application Filing
- 2020-08-28 JP JP2022513603A patent/JP2022546987A/ja active Pending
- 2020-08-28 CA CA3152868A patent/CA3152868A1/en active Pending
-
2022
- 2022-02-27 IL IL290927A patent/IL290927A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rigante et al. | The pharmacologic basis of treatment with colchicine in children with familial Mediterranean fever | |
| JP7171644B2 (ja) | 肥満の治療、重量増加の予防、重量減少の促進、スリミングの促進、又は糖尿病の進行の治療若しくは予防のための方法及び組成物 | |
| ZA200505860B (en) | Compositions comprising fatty acids and amino acids | |
| IL134271A (en) | Pharmaceutical compositions for altering lipids comprising nicotinic acid compounds and hmg-coa reductase inhibitors | |
| ES2380752T3 (es) | Agente profiláctico y/o terapéutico para hiperlipidemia | |
| JPWO2009151116A1 (ja) | 非アルコール性脂肪肝炎の予防／改善・治療薬 | |
| RU2010135514A (ru) | Комбинации пероральных лекарственных средств, соединенных посредством оболочки | |
| CA2951280A1 (en) | Treatment of severe hypertriglyceridemia | |
| NZ532158A (en) | Combinations comprising cox-2 inhibitors and aspirin | |
| AU2005209948B2 (en) | Use of aminosalicylates in diarrhoea-predominent Irritable Bowel Syndrome | |
| JP2010532348A5 (zh) | ||
| WO2006006729A1 (ja) | Ｃ型肝炎ウイルス陽性ヒト肝硬変患者用肝癌発生・進展抑制剤 | |
| JP6359583B2 (ja) | 肝細胞がんの予防及び／又は治療のための医薬 | |
| KR20120089623A (ko) | 정맥내 투여용 이부프로펜을 이용한 환자의 치료 | |
| JPWO2021037212A5 (zh) | ||
| JP6044667B2 (ja) | 耐糖能異常用医薬組成物及び飲食品 | |
| WO2001019350A1 (en) | Controlled release formulation for administration of an anti-inflammatory naphthalene derivative | |
| WO2007091623A1 (ja) | メグリチニド類を含有する肝臓線維化予防用医薬組成物 | |
| EP1121110B1 (en) | Use of metformin to counteract weight gain associated with valproate and other psychotropic medications | |
| JP4715423B2 (ja) | 耐糖能異常用医薬組成物及び飲食品 | |
| JPS5998018A (ja) | 老化治療剤 | |
| JP6454436B1 (ja) | ペマフィブラートを含有する医薬 | |
| IE49652B1 (en) | Improved anti-inflammatory combinations having reduced ulcerogenicity | |
| ES2267796T3 (es) | Uso de fibratos para la preparacion de un medicamento util en el tratamiento de insuficiencia cardiaca congestiva. | |
| WO2003099332A1 (fr) | Composition medicinale pour inhiber l'expression d'atp-citrate lyase et son utilisation |